Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study
Extensive in vitro studies have been conducted to evaluate the anticancer activity of oral hypoglycemic agents. Many of these studies experienced detrimental limitations, since they were conducted on cancer cells commonly grown in culture media consisting of extremely high concentrations of growth f...
Main Authors: | Bardaweel Sanaa K., Alsalamat Husam A., Aleidi Shereen M., Bashatwah Rasha M. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2018-0031 |
Similar Items
-
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
by: Lu Zhang, et al.
Published: (2016-09-01) -
Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
by: Said Izreig, et al.
Published: (2020-05-01) -
Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
by: Giulio Ferrari, et al.
Published: (2011-11-01) -
Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity
by: Federica Barbieri, et al.
Published: (2019-03-01) -
Synthesis, Anti-Proliferative Evaluation and Mechanism of 4-Trifluoro Methoxy Proguanil Derivatives with Various Carbon Chain Length
by: Simeng Xu, et al.
Published: (2021-09-01)